|
|
||||||||
|
Interact CardioVasc Thorac Surg 2009;9:909-910. doi:10.1510/icvts.2009.212076 © 2009 European Association of Cardio-Thoracic Surgery
Heartmate XVE® destination therapy for end-stage heart failure in a patient with human immunodeficiency virus
a Division of Cardiothoracic Surgery, Richard M. Ross Heart Hospital, The Ohio State University Medical Center, 410 W. 10th Avenue, Columbus, OH 43210, USA
*Corresponding author. Tel.: +1 (614) 293-9327; fax: +1 (614) 293-4726. Cardiac dysfunction is a known predictor of survival in patients with acquired immunodeficiency syndrome. In this report, we describe a human immunodeficiency virus (HIV)-infected patient with worsening heart failure who was managed successfully for 16 months with placement of a left ventricular assist device.
Key Words: Left ventricular assist device; HIV positive patient
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |